Contact this trialFirst, we need to learn more about you.
Nrf2 Activator
Vumerity for Peripheral Artery Disease
Recruiting0 awardsPhase < 1
Omaha, Nebraska
This trial aims to investigate whether a medication called diroximel fumarate (Vumerity) can help improve antioxidant capacity, reduce oxidative stress, and enhance vascular function and walking capacity in individuals
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service